Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.81 | N/A |
| PEG Ratio (TTM) | 1.88 | N/A |
| P/S Ratio (TTM) | 1.62 | N/A |
| P/B Ratio (TTM) | 1.01 | N/A |
| P/FCF Ratio (TTM) | 216.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.94 | N/A |
| Price to 5YR AVG FCF Ratio | 3.20 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.62% | N/A |
| ROE (TTM) | 8.24% | N/A |
| Net Profit Margin (TTM) | 12.47% | N/A |
| ROIC 5YR AVG | 5.82% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 62.90% | 28.45% | 6.19% |
| Revenue | -10.40% | -6.82% | -5.16% |
| Net Income | 57.95% | 23.10% | 0.14% |
| Cash Flow | -27.68% | 18.09% | 2.22% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 1.52 | N/A |
| Interest Coverage (TTM) | 0.31 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.68 | N/A |
| LTL to 5YR AVG FCF | 6.48 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.62% | N/A |